Unknown NA INTERVENTIONAL 1-arm NCT02898649

Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer

Sponsor: Yonsei University

Conditions Locally Advanced Pancreatic Cancer

Interventions Irreversible electroporation

Updated 8 times since 2017 Last updated: Feb 13, 2019 Started: Dec 31, 2015 Primary completion: Aug 31, 2019 Completion: Aug 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Locally Advanced Pancreatic Cancer, this trial is ongoing. The trial is conducted by Yonsei University and has accumulated 8 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Mar 2019 — Jan 2021 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting
Jan 2019 — Mar 2019 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — Jan 2019 [monthly]

Recruiting NA

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yonsei University

Data source: Yonsei University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea